Treatment of cancer with specific RXR agonists
Details for Australian Patent Application No. 2006299645 (hide)
International Classifications
Event Publications
24 April 2008 PCT application entered the National Phase
PCT publication WO2007/041398 Priority application(s): WO2007/041398
20 January 2011 Assignment before Grant
Vitae Pharmaceuticals, Inc. The application has been assigned to IO Therapeutics
3 February 2011 Application Accepted
Published as AU-B-2006299645
2 June 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006299642-Stabilizers and compositions and products comprising same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser